As shown in Figure 1, the levels of chemerin were significantly decreased in AML patients (0.0000-1.3786, median 0.0151) compared with healthy controls (0.0000-88.5733, median 0.0855, P=0.042). This evidence concerns the gene RARRES2 and acute myeloid leukemia.